Meeting Banner
Abstract #0760

Preliminary study about T2 mapping technology in quantification of uterine benign and malignant tumors under 1.5T and 3.0T MRI

Liuhong Zhu1, Pu-Yeh Wu2, Hao Liu1, and Jianjun Zhou1
1Radiology, Xiamen Branch, Zhongshan Hospital, Fudan University, Xiamen, China, 2GE Healthcare, Beijing, China

MRI is the best imaging tool for evaluation of uterine tumors, but conventional MRI diagnosis results are subjective. T2 mapping is an objective quantification technique under certain magnetic field. Here we compared T2 values of common benign and malignant tumors under different field strengths. We found that T2 value of benign lesions was significantly lower than those of malignant lesions under both 1.5T and 3.0T, while diagnostic performance of T2 value under 3.0T were higher than 1.5T. We concluded that T2 mapping can be an effective quantitative tool in distinguishing between benign and malignant tumors, especially under 3.0T MR.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.

Keywords